Basal Cell Carcinoma News and Research

RSS
Basal cell cancer begins in the lowest layer of the epidermis, the basal cell layer. About 8 out of 10 skin cancers are basal cell carcinomas. They usually begin on areas exposed to the sun, such as the head and neck. Basal cell carcinoma was once found mostly in middle-aged or older people. But now it is also being seen in younger people. This may be because people are spending more time in the sun without protecting their skin.

Basal cell carcinoma tends to grow slowly. It is very rare for a basal cell cancer to spread to distant parts of the body (metastasize). But if it is not treated, it can grow into nearby areas and spread into the bone or other tissues beneath the skin.

After treatment, basal cell carcinoma can come back (recur) in the same place on the skin. New basal cell cancers can also start in other places on the skin. As many as half of the people who have one basal cell cancer will get a new skin cancer within 5 years.
Topical cream shows signs of clinical efficacy in patients with basal cell carcinoma

Topical cream shows signs of clinical efficacy in patients with basal cell carcinoma

Compound isolated from Ophiura sarsii can be used as an affordable drug for photodynamic therapy

Compound isolated from Ophiura sarsii can be used as an affordable drug for photodynamic therapy

Yale scientists develop an injection-based therapy for skin cancer

Yale scientists develop an injection-based therapy for skin cancer

Study explores link between personal use of hair dyes and cancer risk

Study explores link between personal use of hair dyes and cancer risk

IU researcher identifies new genomic regions that increase skin cancer risk

IU researcher identifies new genomic regions that increase skin cancer risk

Researchers develop new isolated limb infusion method for melanoma treatment

Researchers develop new isolated limb infusion method for melanoma treatment

GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma

GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma

Melanoma patients report 95% satisfaction rate with Mohs surgery

Melanoma patients report 95% satisfaction rate with Mohs surgery

ACCC project develops resources to support treatment of patients with cutaneous squamous cell carcinoma

ACCC project develops resources to support treatment of patients with cutaneous squamous cell carcinoma

Leukemia drug appears to be effective in treating deadly pediatric brain tumor

Leukemia drug appears to be effective in treating deadly pediatric brain tumor

Study identifies key epigenetic regulator that controls skin cell turnover

Study identifies key epigenetic regulator that controls skin cell turnover

New Milford Hospital’s Eating Well program offers comfort to patients and caregivers

New Milford Hospital’s Eating Well program offers comfort to patients and caregivers

GW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma

GW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma

Limiting UV exposure is the number one way to reduce rising female skin cancer rates

Limiting UV exposure is the number one way to reduce rising female skin cancer rates

Research sheds light on sun-induced DNA damage and repair

Research sheds light on sun-induced DNA damage and repair

GW researchers underscore need for tailored skin cancer prevention programs

GW researchers underscore need for tailored skin cancer prevention programs

Wear protective clothing to reduce the risk of skin damage from sun's UV rays

Wear protective clothing to reduce the risk of skin damage from sun's UV rays

Artificial intelligence better than humans in diagnosing pigmented skin lesions

Artificial intelligence better than humans in diagnosing pigmented skin lesions

Research identifies super-enhancers as novel target for pancreatic ductal adenocarcinoma

Research identifies super-enhancers as novel target for pancreatic ductal adenocarcinoma

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

Nine early career scientists named 2019 recipients of the Damon Runyon-Rachleff Innovation Award

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.